The paper "Accuracy and Scaling Phenomena in Internet Mapping", by Aaron
Clauset and Prof. Cristopher Moore, will be published in the prestigious
Physics Review Letters (PRL). It explores the inherent sampling
bias in using traceroutes to map the Internet's topology, and discusses how
many additional sources are needed to make better maps.
A preprint of the article is available.
Eugene ("Spaf") Spafford will discuss current research trends and how
they relate to the four
grand challenges in Trustworthy Computing. The colloquium happens
Monday, November 15, 2004, from 2:30pm to 4:30 in Woodward
149—note the changed time.
Prof. Spafford teaches at Purdue University. He is a major figure in the
computer security/infosec area, having built the first open scanner,
widely-available intrusion detection tool, and the first formal bounds on
intrusion detection, among many other accomplishments.
Ken Perlin will discuss
contingent narratives and effective virtual actors as they relate to
computer-mediated interactive media. Prof. Perlin won an Academy Award in
1997 for his work with noise and turbulence procedural texturing techniques,
which are now widely used in films and television.
The colloquium happens Tuesday, October 26th, 2004, from 11am to 12:15pm in Woodward 149.
David Cohn, a senior research scientist at Google, will give a colloquium
on "Inference of, for and by the Web - Machine Learning Challenges at
Google", Tuesday, October 19th, 2004, from 11am to 12:15pm in Woodward 149.
David will discuss what it's like to be "...in the heart of a company searching terabytes of data to serve over 200 million queries a day."
The UNM Engineering Magazine recently featured Prof. Paul Helman and Robert Veroff for their interdisciplinary work with Cheryl L. Willman, director of the UNM Cancer Research and Treatment Center, in finding a gene which may save the lives of children with leukemia. The professors used a Bayesian net to find the Outcome Predictor for Acute Leukemia 1 (OPAL1) gene, which is "...extremely predictive of whether or not someone would survive their leukemia", said Prof. Helman.